Clinical data indicate that prognostic stratification of radically resected colorectal cancer based on disease stage only may not be always be adequate. Preclinical findings suggest that cancer stem cells may influence the biological behaviour of colorectal cancer independently from stage: objective of the study was to assess whether a panel of stemness markers were correlated with clinical outcome in resected stage II and III colon cancer patients. A panel of 66 markers of stemness were analysed and thus patients were divided into two groups (A and B) with most patients clustering in a manner consistent with different time to relapse by using a statistical algorithm. A total of 62 patients were analysed. Thirty-six (58%) relapsed during the follow-up period (range 1.63-86.5 months). Twelve (19%) and 50 (81%) patients were allocated into group A and B, respectively. A significantly different median relapse-free survival was observed between the 2 groups (22.18 vs 42.85 months, p=0.0296). Among of all genes tested, those with the higher "weight" in determining different prognosis were CD44, ALCAM, DTX2, HSPA9, CCNA2, PDX1, MYST1, COL1A1 and ABCG2. This analysis supports the idea that, other than stage, biological variables, such as expression levels of colon cancer stem cell genes, may be relevant in determining an increased risk of relapse in resected colorectal cancer patients

Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients / Giampieri, R; Scartozzi, M; Loretelli, C; Piva, F; Mandolesi, A; Lezoche, G; Del Prete, M; Bittoni, A; Faloppi, L; Bianconi, M; Cecchini, L; Guerrieri, M; Bearzi, I; Cascinu, Stefano. - In: PLOS ONE. - ISSN 1932-6203. - 8:9(2013), pp. 1-6. [10.1371/journal.pone.0072843]

Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.

CASCINU, Stefano
2013

Abstract

Clinical data indicate that prognostic stratification of radically resected colorectal cancer based on disease stage only may not be always be adequate. Preclinical findings suggest that cancer stem cells may influence the biological behaviour of colorectal cancer independently from stage: objective of the study was to assess whether a panel of stemness markers were correlated with clinical outcome in resected stage II and III colon cancer patients. A panel of 66 markers of stemness were analysed and thus patients were divided into two groups (A and B) with most patients clustering in a manner consistent with different time to relapse by using a statistical algorithm. A total of 62 patients were analysed. Thirty-six (58%) relapsed during the follow-up period (range 1.63-86.5 months). Twelve (19%) and 50 (81%) patients were allocated into group A and B, respectively. A significantly different median relapse-free survival was observed between the 2 groups (22.18 vs 42.85 months, p=0.0296). Among of all genes tested, those with the higher "weight" in determining different prognosis were CD44, ALCAM, DTX2, HSPA9, CCNA2, PDX1, MYST1, COL1A1 and ABCG2. This analysis supports the idea that, other than stage, biological variables, such as expression levels of colon cancer stem cell genes, may be relevant in determining an increased risk of relapse in resected colorectal cancer patients
2013
8
9
1
6
Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients / Giampieri, R; Scartozzi, M; Loretelli, C; Piva, F; Mandolesi, A; Lezoche, G; Del Prete, M; Bittoni, A; Faloppi, L; Bianconi, M; Cecchini, L; Guerrieri, M; Bearzi, I; Cascinu, Stefano. - In: PLOS ONE. - ISSN 1932-6203. - 8:9(2013), pp. 1-6. [10.1371/journal.pone.0072843]
Giampieri, R; Scartozzi, M; Loretelli, C; Piva, F; Mandolesi, A; Lezoche, G; Del Prete, M; Bittoni, A; Faloppi, L; Bianconi, M; Cecchini, L; Guerrieri, M; Bearzi, I; Cascinu, Stefano
File in questo prodotto:
File Dimensione Formato  
journal.pone.0072843.PDF

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 262.07 kB
Formato Adobe PDF
262.07 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1079323
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 34
social impact